These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18819401)

  • 21. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
    Straskova A; Cerveny L; Spidlova P; Dankova V; Belcic D; Santic M; Stulik J
    Microbes Infect; 2012 Feb; 14(2):177-87. PubMed ID: 21930232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia.
    Fulop M; Manchee R; Titball R
    Vaccine; 1995 Sep; 13(13):1220-5. PubMed ID: 8578807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages.
    Clemens DL; Lee BY; Horwitz MA
    Infect Immun; 2004 Jun; 72(6):3204-17. PubMed ID: 15155622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS.
    Dueñas AI; Aceves M; Orduña A; Díaz R; Sánchez Crespo M; García-Rodríguez C
    Int Immunol; 2006 May; 18(5):785-95. PubMed ID: 16574669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.
    Lu Z; Roche MI; Hui JH; Unal B; Felgner PL; Gulati S; Madico G; Sharon J
    Immunol Lett; 2007 Oct; 112(2):92-103. PubMed ID: 17764754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
    Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
    Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica.
    Stenmark S; Lindgren H; Tärnvik A; Sjöstedt A
    Microb Pathog; 2003 Aug; 35(2):73-80. PubMed ID: 12901846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.
    Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL
    Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of lipopolysaccharide in toxicity of Francisella genus bacteria].
    Onoprienko NN; Pavlovich NV
    Mol Gen Mikrobiol Virusol; 2003; (3):25-8. PubMed ID: 12966923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nature of protective immunity to Francisella tularensis.
    Tärnvik A
    Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Characterization of structure and antigenic activity of lipopolysaccharides of genus Francisella].
    Maslova NN; Pavlovich NV; Sorokin VM; Zurabian VA
    Mol Gen Mikrobiol Virusol; 1998; (3):26-9. PubMed ID: 9819824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.
    Ryden P; Twine S; Shen H; Harris G; Chen W; Sjostedt A; Conlan W
    Mol Immunol; 2013 May; 54(1):58-67. PubMed ID: 23201853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The preventive activity of monoclonal antibodies specific to the lipopolysaccharide of Francisella tularensis].
    Khlebnikov VS; Vetchinin SS; Grechko GK; Averina AA; Golovlev IR; Averin SF; Zhemchugov VE; Konovalov SI; Anisimov GA; Afanas'ev SS
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (9-10):67-70. PubMed ID: 1481610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia.
    Havlasová J; Hernychová L; Brychta M; Hubálek M; Lenco J; Larsson P; Lundqvist M; Forsman M; Krocová Z; Stulík J; Macela A
    Proteomics; 2005 May; 5(8):2090-103. PubMed ID: 15892173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-LPS targets and actions of LPS binding protein (LBP).
    Schröder NW; Schumann RR
    J Endotoxin Res; 2005; 11(4):237-42. PubMed ID: 16176661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS.
    Mathison JC; Tobias PS; Wolfson E; Ulevitch RJ
    J Immunol; 1992 Jul; 149(1):200-6. PubMed ID: 1607653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS.
    Sandström G; Sjöstedt A; Johansson T; Kuoppa K; Williams JC
    FEMS Microbiol Immunol; 1992 Oct; 5(4):201-10. PubMed ID: 1419118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and functional features of a developmentally regulated lipopolysaccharide-binding protein.
    Krasity BC; Troll JV; Lehnert EM; Hackett KT; Dillard JP; Apicella MA; Goldman WE; Weiss JP; McFall-Ngai MJ
    mBio; 2015 Oct; 6(5):e01193-15. PubMed ID: 26463160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
    Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
    Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.